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The Etiological Role of Common Respiratory Viruses in 
Acute Respiratory Infections in Older Adults: A Systematic 
Review and Meta-analysis
Ting Shi,1 Andrew Arnott,1 Indre Semogas,1 Ann R. Falsey,3,4 Peter Openshaw,2 Jadwiga A. Wedzicha,2 Harry Campbell,1,  and Harish Nair,1,4,   
for the RESCEU Investigators
1Centre for Global Health Research, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, and 2National Heart and Lung Institute, Imperial 
College London, United Kingdom; and 3University of Rochester School of Medicine, New York; and 4ReSViNET Foundation, Zeist, The Netherlands
Acute respiratory tract infections (ARI) constitute a substantial disease burden in adults and elderly individuals. We aimed to iden-
tify all case-control studies investigating the potential role of respiratory viruses in the etiology of ARI in older adults aged ≥65 years. 
We conducted a systematic literature review (across 7 databases) of case-control studies published from 1996 to 2017 that investi-
gated the viral profile of older adults with and those without ARI. We then computed a pooled odds ratio (OR) with a 95% confidence 
interval and virus-specific attributable fraction among the exposed (AFE) for 8 common viruses: respiratory syncytial virus (RSV), 
influenza virus (Flu), parainfluenza virus (PIV), human metapneumovirus (HMPV), adenovirus (AdV), rhinovirus (RV), bocavi-
rus (BoV), and coronavirus (CoV). From the 16 studies included, there was strong evidence of possible causal attribution for RSV 
(OR, 8.5 [95% CI, 3.9–18.5]; AFE, 88%), Flu (OR, 8.3 [95% CI, 4.4–15.9]; AFE, 88%), PIV (OR, not available; AFE, approximately 
100%), HMPV (OR, 9.8 [95% CI, 2.3–41.0]; AFE, 90%), AdV (OR, not available; AFE, approximately 100%), RV (OR, 7.1 [95% CI, 
3.7–13.6]; AFE, 86%) and CoV (OR, 2.8 [95% CI, 2.0–4.1]; AFE, 65%) in older adults presenting with ARI, compared with those 
without respiratory symptoms (ie, asymptomatic individuals) or healthy older adults. However, there was no significant difference in 
the detection of BoV in cases and controls. This review supports RSV, Flu, PIV, HMPV, AdV, RV, and CoV as important causes of ARI 
in older adults and provides quantitative estimates of the absolute proportion of virus-associated ARI cases to which a viral cause 
can be attributed. Disease burden estimates should take into account the appropriate AFE estimates (for older adults) that we report.
Keywords. Etiological role; respiratory virus; acute respiratory infection; older adults.
 
Acute respiratory tract infections (ARI), including pneumonia, 
constitute a substantial disease burden in adults and elderly 
individuals. Respiratory viruses are detected more frequently 
than bacteria in adults with pneumonia [1]. The substantial 
contribution of viruses to ARI hospitalizations among adults is 
being increasingly recognized [2, 3].
Although influenza virus (Flu) is the most widely recognized 
viral infection associated with respiratory illness, >25 viruses 
have been linked to pneumonia, causing a substantial disease 
burden in adults and elderly individuals. These include com-
mon pathogens such as rhinovirus (RV), respiratory syncytial 
virus (RSV), Flu, human metapneumovirus (hMPV), parainflu-
enza viruses (PIV), and human coronaviruses (CoVs) [2]. RSV 
is associated with a substantial disease burden in adults, espe-
cially among older adults (aged ≥65 years) [4]. Moreover, adults 
hospitalized with RSV disease can develop severe respiratory 
complications [5]. RV has been associated with severe respira-
tory disease outbreaks in adults in long-term care facilities in 
several settings [6]. Despite advances in diagnostic technology, 
defining the specific causes of viral pneumonia is challenging, 
particularly among older adults who may have lower viral loads 
and for whom viral diagnosis is frequently not considered and/
or testing is not performed [7]. Therefore, it is necessary to mea-
sure concurrently the background prevalence of nasopharyngeal 
viral infection in a control (asymptomatic) group, to investigate 
the etiological role of viruses in older adults with ARI to help 
inform decisions on prevention and management strategies.
Previously, we have conducted a systematic review to under-
stand the etiological role of common respiratory viruses, focus-
ing on children aged <5 years [8]. To the best of our knowledge, 
similar estimates for adults are lacking. Therefore, we aimed to 
conduct a similar systematic review to identify all case-control 
studies since 1996 investigating the potential role of respiratory 
viruses in the etiology of ARIs in older adults aged ≥65 years.
METHODS
Search Strategy and Selection Criteria
We conducted a systematic review across 7 databases (includ-
ing 3 Chinese databases) following the approach detailed in the 
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PRISMA (Preferred Reporting Items for Systematic Reviews 
and Meta-analyses) guidelines [9]. Tailored search strategies 
were developed and used to search the Medline, Embase, Global 
Health, LILACS, China National Knowledge Infrastructure 
(CNKI), Wanfang Data, and Chongqing VIP databases 
(Appendix). We further searched the reference lists of relevant 
articles for eligible articles. All searches were limited to between 
January 1996 and August 2017. No publication status criteria or 
language restrictions were used. We included studies that ful-
filled the following selection criteria (Supplementary Figure 1).
Three investigators (T. S., A. A., and I. S.) conducted indepen-
dent searches of the English-language literature and extracted 
data by using standardized data extraction templates. One 
investigator (T. S.), whose first language is Chinese, searched 
and extracted data from Chinese-language databases (ie, CNKI, 
Wanfang, and CQVIP).
The protocol of this review was published in the PROSPERO 
database (no. CRD42017083332).
Definitions
The case group was defined as older adults with ARI or pneumo-
nia aged ≥65 years, adapted from World Health Organization 
Integrated Management of Adolescent and Adult Illness [10]. 
The details of the definitions are displayed in Supplementary 
Table  1. The control group was defined as older adults aged 
≥65 years who were either healthy or did not have any respira-
tory symptoms. We categorized countries as either industrial-
ized or developing, on the basis of 2015 criteria from the United 
Nations Children’s Fund [11].
Statistical Analysis
We calculated odds ratios (ORs) as the ratio of the odds of detect-
ing each virus in older adults with ARI or pneumonia to the odds 
of detecting each virus in healthy or asymptomatic controls, with 
accompanying 95% confidence intervals (CIs). We used a con-
tinuity correction of 0.0005 if a virus was detected in one group 
but not the other [12]. This allowed calculation of an OR for these 
instances and enabled inclusion in subsequent meta-analyses.
Using Stata (version 13.0), we performed a meta-analysis of 
virus-specific ORs and reported pooled meta-estimates with 
corresponding 95% CIs, using the random effects model (ie, the 
DerSimonian-Laird method) because the included studies are 
heterogeneous in various aspects and are thus assumed to have 
different effect sizes [13]. The virus-specific attributable fraction 
among the exposed (AFE) was used to quantify the etiological 
role of each virus in patients with ARI. This is an estimate of the 
percentage of ARIs that can be attributed to each virus, in abso-
lute terms [14], and was calculated as 100 * [OR − 1]/OR, with a 
95% CI (from the corresponding 95% CI of the OR). Moreover, 
for a specific virus, if all included studies did not report any 
virus detection in one group consistently (usually the control 
group), we assumed that a strong association indicating a possi-
ble causal role for this virus in ARI could be concluded. In these 
circumstances, we considered that there was no need to run a 
meta-analysis that would only result in an extremely high OR 
point estimate and an AFE approaching 100%.
RESULTS
We identified 4327 (239 from Chinese databases) records 
through the literature search and 5 records from the reference 
lists of relevant articles. Among them, only 16 studies (includ-
ing 2 from Chinese databases) fulfilled our inclusion and exclu-
sion criteria (Figure  1) [1, 15–29]. Forty-three studies were 
excluded for a variety of reasons: no data specific to older adults 
≥65 years old were available (n = 1), the case or control defi-
nitions were not fulfilled (n = 4), no applicable data for cases 
and controls were reported (n = 36), or serum was used as the 
clinical specimen (n = 2). Seven studies were conducted within 
developing countries, while 9 were from developed countries 
(Supplementary Table 2). Although the search was performed 
for articles published since 1996, all included studies were pub-
lished since 2003.
All included studies were case-control studies with adults 
who had ARI or pneumonia in the case group and asympto-
matic or healthy adults in the control group. Methods varied 
among studies. Among the case definitions used, 7 studies used 
ARI or acute lower respiratory tract infection, while the others 
used (severe) pneumonia (n = 9). All studies investigated a con-
trol group, which had no respiratory symptoms, and in 3 studies 
healthy older adults (without acute illness) served as controls. 
Of the case ascertainment methods used, 8 articles recruited 
the cases from inpatients; 1, from outpatients; 3, from general 
practices; 1, from the community; and 3, from mixed settings 
(outpatient settings and the emergency department, and both 
outpatient and inpatient settings). In 11 studies, controls were 
ascertained in hospital-based outpatient or clinic sites, whereas 
in 5 studies, controls were identified from the community. All 
studies collected a mixture of nasopharyngeal swab specimens, 
nasopharyngeal aspirates, nasopharyngeal washes, oropharyn-
geal swab specimens, and nasal/throat swab specimens as the 
clinical specimen. All studies used polymerase chain reaction 
analysis (PCR; in some, PCR was combined with serologic anal-
ysis or culture) as the diagnostic test.
Meta-analyses of virus-specific ORs are reported as well as 
the corresponding attributable fractions among the exposed 
(Supplementary Table  3). RSV, Flu (including Flu A), hMPV, 
RV, and CoV (also CoV OC43 and 229E) were significantly 
more common in older adults with a diagnosis of ARI or pneu-
monia than in asymptomatic or healthy controls (ORs, 8.5 [95% 
CI, 3.9–18.5], 8.3 [95% CI, 4.4–15.9], 9.8 [95% CI, 2.3–41.0], 
7.1 [95% CI, 3.7–13.6], and 2.8 [95% CI, 2.0–4.1], respectively). 
These viruses had statistically significant positive AFEs, which 
showed clear associations between these viruses and ARI or 
pneumonia in older adults. Moreover, PIV (including PIV1 
and PIV3; data for PIV2 and PIV4 were not available), Flu B, 
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and AdV were only identified in cases consistently across all 
included studies (8, 5, and 8 studies, respectively) and absent 
in control groups. Thus, these viruses were all assumed to have 
strong associations with ARI. Only 2 studies had data availa-
ble for BoV, and although both reported virus detection in a 
greater proportion of cases than controls [18, 28], the associa-
tion remains a question for further research.
A subgroup analysis was performed to explore the roles of 
viruses in ARI with respect to region: developing countries and 
industrialized countries. The meta-estimate OR was higher in 
industrialized countries as compared to developing countries in 
the case of Flu (with overlapping 95% CIs), while it was similar 
for PIV, AdV, and RV. There were insufficient studies to con-
duct a similar subgroup analysis for other viruses. A sensitivity 
analysis was performed to investigate the roles of these com-
mon viruses in older adults admitted to hospitals with ARI or 
pneumonia [1, 16, 20, 22, 23, 25, 27, 28]. Eight studies were 
included, and results are presented in Supplementary Table 4. 
The meta-estimate OR did not differ significantly from the pre-
vious estimate, in which cases from other settings (ie, outpatient 
and general practice settings) were also included.
DISCUSSION
This is the first systematic review to evaluate and summarize the 
literature that includes concurrent control data on the viral eti-
ology of ARI in older adults. Our review summarized data from 
5560 cases of ARI in older adults reported across 16 studies. We 
demonstrated strong evidence in support of a potential causal 
attribution when a virus is identified in older adults presenting 
with ARI or pneumonia for RSV (OR, 8.5 [95% CI, 3.9–18.5]; 
AFE, 88%), Flu (OR, 8.3 [95% CI, 4.4–15.9]; AFE, 88%), PIV 
(OR, not available [NA]; AFE, approximately 100%), hMPV 
(OR, 9.8 [95% CI, 2.3–41.0]; AFE, 90%), AdV (OR, NA; AFE, 
approximately 100%), RV (OR, 7.1 [95% CI, 3.7–13.6]; AFE, 
86%), and CoV (OR, 2.8 [95% CI, 2.0–4.1]; AFE, 65%). This 
supports an etiological role of RSV, Flu, PIV, hMPV, AdV, RV, 
and CoV in ARI and pneumonia in older adults, thereby indi-
cating a potential for substantive reductions in the number of 
ARI cases if older adults were vaccinated against these viruses 
or treated with antivirals. For the other respiratory viruses 
studied, the role of BoV in ARI and pneumonia was uncertain 
because of the limited evidence available from the published lit-
erature, requiring more research to clarify its role in older adults 
with ARI. A sensitivity analysis focusing only on older adults 
who were admitted to hospitals with ARI or pneumonia did not 
differ significantly from our estimate, in which patients from 
all settings were considered. This might result from the limited 
number of studies available to provide a more robust sensitivity 
analysis. No studies calculated adjusted ORs to account for con-
founding effects from age or season, which might compromise 
the actual association and should be considered in the study 
design in future research.
These findings should inform the results of studies that seek 
to estimate the global, regional, and national burden of disease 
due to these viruses in older adults [30]. They show that RSV, 
Flu, PIV, hMPV, AdV, RV, and CoV are important causes of ARI 
4327 records identified
through database search
5 records identified
through other sources
683 duplicates removed
3649 records screened
59 full-text articles
assessed for eligibility
16 studies included
3590 records excluded
because of  irrelevance to topic
43 full-text articles excluded:
1 article had no data specific to
elderly adults ≥65 years old;
36 articles had no relevant data;
4 studies had an improper
definition ar design;
2 studies used serum as a specimen
Figure 1. PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-analyses) flow diagram of the literature search.
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in older adults, and disease burden estimates should take into 
account the appropriate AFE estimates (for older adults) that we 
report, rather than the AFE estimates in children aged <5 years. 
There is considerable international attention on RSV-associated 
ARI in older adults at this time, during which novel vaccine 
and antiviral strategies are being evaluated and prioritized [31, 
32], and more-accurate disease burden estimates (using these 
results) would help to inform future policies and interventions.
The prevalence of virus detection from etiologic studies of 
pneumonia in adults is substantially lower than the detection rate 
in studies of children. The EPIC (Etiology of Pneumonia in the 
Community) study team showed that the viruses were detected in 
26% of adults who had been hospitalized with community-acquired 
pneumonia, compared with 73% of children who were admitted to 
the hospital [1, 33]. There are several reasons for such low levels 
of detection, such as the inability to obtain lower respiratory tract 
specimens, the use of diagnostic tests with insufficient sensitivity, 
the absence of appropriate diagnostic testing methods, the unde-
tectability of the virus at the time of the study, and the presence 
of unknown pathogens that were not identified. The low rate of 
virus detection among adults who were hospitalized for pneumo-
nia highlights the need for more-sensitive diagnostic approaches, 
innovative discovery of pathogens, and assessing viruses in the 
past history (weeks before the presence of disease) [34]. Moreover, 
chronic obstructive pulmonary disease (COPD) exacerbation is a 
very important cause of ARIs and hospital admissions [35]. Only 7 
of 16 studies included COPD in the etiologic data, and this infor-
mation was unclear in the remaining studies, which might have 
underestimated the role of viral infection in these patients.
A previous etiological review focusing on young children 
aged <5  years [8] showed that RSV, Flu (including Flu A), 
PIV, hMPV, and RV were significantly more common in chil-
dren hospitalized with acute lower respiratory tract infection 
than asymptomatic controls. The associations of these viruses 
(except RSV) with ARI and pneumonia were stronger among 
adults. This is in part because, in comparison to young children, 
the detection of viruses in the control group (ie, among individ-
uals without respiratory symptoms or healthy controls) was less 
common in older adults, with the exception of RSV.
Several methodological issues could affect our results: sample 
size, age group, case ascertainment, clinical specimen, and diag-
nostic testing. Although a thorough search has been performed 
across 7 databases, including 3 Chinese-language databases, only 
16 studies from the published literature were identified, which 
met our selection criteria. Not every virus of interest was tested 
in each study. The number of studies available was even smaller 
when subgroup analyses and sensitivity analyses were performed. 
Moreover, the sample size varied from 50 to 2320 adults in the 
case group and from 27 to 541 adults in the control group. The 
small sample size undoubtedly contributed to the imprecise 95% 
CIs around the ORs. Thus, we may have failed to detect clinically 
significant ARI-virus associations, owing to small sample sizes.
We aimed to stratify the association between common 
respiratory viruses in adults with ARI or pneumonia by age. 
However, most articles did not stratify and report data by 
age group. Instead, they summarized the result for the entire age 
group, usually in adults aged >18 years. Therefore, some of our 
meta-estimate ORs may not be representative of older adults 
who are aged ≥65 years. Since age might be a risk factor for ARI 
in adults (the rate of severe ARI increases as age advances), this 
could potentially affect the viral profile detected, introducing 
further heterogeneity [1].
Fifteen of 16 studies used passive clinic or hospital based 
case ascertainment. Among them, cases were recruited from 
inpatients, outpatients, emergency departments, or general 
practices, which might reflect different healthcare behavior and 
disease severity. Also, since the episodes of ARI and pneumo-
nia were only diagnosed through routine care, this introduced 
bias, considering that testing was only done when the clinicians 
deemed it necessary to test. Similarly, 5 studies used communi-
ty-based controls, while another 11 studies recruited older adult 
controls from hospitals or general practices. Hospital or clini-
cal ascertained controls may not reflect the general population 
and may have other health conditions potentially affecting their 
viral carriage. Moreover, recruiting controls who were selected 
as healthy or without respiratory symptoms could favor those 
who were not exposed to the respiratory virus (yielding a falsely 
high OR). Therefore, we consider that the ideal control group 
for these studies would be a random sample of an age- and sex-
matched population of older adults who are from the same area 
of residence and studied at the same time as cases.
All included studies obtained upper respiratory tract specimens 
(described as nasopharyngeal secretions). Assays might have spec-
imen-specific sensitivities and specificities for detecting viruses, 
which could lead to heterogeneity in the estimation of virus-spe-
cific rates. The sensitivity of using nasopharyngeal washes for 
detecting any virus in adults was found to be higher than that for 
using nasopharyngeal swab specimens, which in turn was higher 
than that for using oropharyngeal swab specimens (84.9%, 73.3%, 
and 54.2%, respectively) [36]. The limited use (due to ethical con-
cerns and feasibility) of invasive procedures to obtain lower respi-
ratory tract specimens directly from the lung also influenced the 
diagnosis of viral infection in adults with ARI [37].
PCR and serology-based diagnostic testing are more sensitive 
for detecting respiratory viruses than other methods, such as 
antigen detection and culture. High sensitivity is important for 
accurate assessment of etiological contribution, particularly in 
older adults who may have a lower nasopharyngeal viral load 
and an atypical clinical presentation [7]. Moreover, despite 
being uncommon, detection of viral coinfection (range across 
studies, 1%–10%) may tend to overstate the contribution of 
individual respiratory viruses (although dual or multiple infec-
tions, in which both or several viruses have etiological impor-
tance, are possible). Bacterial coinfections (range across studies, 
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15%–26%) were also reported. With improving diagnostic 
methods, multiple etiological agents are increasingly identified 
simultaneously in older adults with ARI, making the individual 
contribution of each agent difficult to define.
Viruses can be detected in individuals with no respiratory symp-
toms. This is often seen in volunteer challenge studies and in some 
community surveys [38, 39]. The detection of viruses in control 
groups without respiratory symptoms might be due to a nascent 
infection or a persisting colonization from a previous infection 
[40]. These factors will tend to result in true associations being 
attenuated. The fact that molecular detection of viruses in older 
adults with ARI is higher than the detection rate in controls with-
out respiratory symptoms may not necessarily indicate causation. 
Alternative explanations should be considered first before causal-
ity can be concluded. These include the respiratory viral infection 
acting as a so-called innocent bystander, without a causal role, and 
serving only as a predisposing risk factor for ARI. Similarly, the 
absence of a positive association (and AFE) does not mean that 
a virus is not a cause of ARI. Moreover, without establishing the 
temporal sequence of exposure and outcome, determinations of 
causality are less secure. Therefore, the association between viruses 
and ARI and pneumonia should be interpreted carefully.
In conclusion, this review provides clear evidence that is sug-
gestive of the potentially causal role of RSV, Flu, PIV, hMPV, 
AdV, RV, and CoV in older adults with ARI and presents the first 
estimate of the proportion of ARI cases that can be attributed to 
virus exposure. Etiological studies, which simply report rates 
of viral identification as causal, should make attempts to inter-
pret findings in terms of the proportion of ARI cases among 
older adults in whom a respiratory virus is identified that can be 
attributed to this viral exposure.
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